Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation

被引:0
|
作者
Toft-Petersen, Anne Pernille [1 ]
Lee, Christina J. -y. [1 ]
Phelps, Matthew [2 ]
Ozenne, Brice [3 ,4 ]
Gerds, Thomas Alexander [5 ]
Torp-Pedersen, Christian [1 ,2 ,5 ]
机构
[1] Univ Copenhagen, Nordsjaellands Hosp, Dept Cardiol & Clin Res, Hillerod, Denmark
[2] Danish Heart Fdn, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Sect Biostat, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit & BrainDrugs, Copenhagen, Denmark
[5] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
来源
PLOS ONE | 2024年 / 19卷 / 11期
关键词
ORAL ANTICOAGULANTS; RISK SCORES; STROKE; WARFARIN; HEMORRHAGE; THERAPY; REGISTRY; SCHEMES; ORBIT;
D O I
10.1371/journal.pone.0312294
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Anticoagulation in atrial fibrillation (AF) increases the risk of major bleeding. No predictive model has hitherto provided estimates of the absolute risk for individual patients. Aim To predict the individual 1-year risk of major bleeding in patients with AF taking anticoagulants and evaluate the importance of individual risk factors. Design A nationwide register-based cohort study. Participants Danish patients with first-time non-valvular AF who redeemed anticoagulants within 7 days after diagnosis. Method The individual absolute risk of major bleeding was estimated from a logistic regression model (the Calculator of Absolute Bleeding Risk/CABS model) utilising the same risk factors as HAS-BLED, except allowing non-linear age effects, and allowing effect modification of all factors according to history of bleeding. The logistic regression was assessed in term of discrimination using the Area Under the ROC curve (AUC) and calibration. Results Among 76,102 patients with AF redeeming anticoagulants, 2,406 suffered a major bleeding within 1 year. History of bleeding was the strongest predictor, and age significantly modified the risk. The CABS model superseded HAS-BLED score with regards to discrimination (AUC 0.646 vs 0.615, p<0.001) and calibrated well. A typical male patient was 70-years old without any risk factors and he had a 1-year bleeding risk of 1.4% (1.2; 1.6) while a typical female patient was 73-years old, had hypertension and a 1-year bleeding risk of 2.2% (1.9;2.6). Conclusion We propose CABS as a tool for prediction of individual absolute risks of major bleeding in patients with AF taking anticoagulant. The predicted absolute risk can be used for patient counselling.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation
    Carlin, Stephanie
    Eikelboom, John
    CANADIAN JOURNAL OF CARDIOLOGY, 2024, 40 (07) : 1291 - 1293
  • [2] Restarting of anticoagulation in patients with atrial fibrillation after major bleeding: A meta-analysis
    Zhou, Ying
    Guo, Yujie
    Liu, Daihua
    Feng, Haiyan
    Liu, Jie
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (04) : 591 - 601
  • [3] Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem
    Harrington, Josephine
    Granger, Christopher B.
    EUROPEAN HEART JOURNAL, 2022, 43 (47) : 4909 - 4911
  • [4] Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
    Adeboyeje, Gboyega
    Sylwestrzak, Gosia
    Barron, John J.
    White, Jeff
    Rosenberg, Alan
    Abarca, Jacob
    Crawford, Geoffrey
    Redberg, Rita
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09) : 968 - 978
  • [5] Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation
    Siegbahn, Agneta
    Lindback, Johan
    Hijazi, Ziad
    Aberg, Mikael
    Alexander, John H.
    Eikelboom, John W.
    Lopes, Renato D.
    Pol, Tymon
    Oldgren, Jonas
    Granger, Christopher B.
    Yusuf, Salim
    Wallentin, Lars
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (11) : 2726 - 2737
  • [6] Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
    Wintgens, L. I. S.
    Vorselaars, V. M. M.
    Klaver, M. N.
    Swaans, M. J.
    Alipour, A.
    Rensing, B. J. W. M.
    Post, M. C.
    Boersma, L. V. A.
    NETHERLANDS HEART JOURNAL, 2019, 27 (12) : 613 - 620
  • [7] Anticoagulation-Related Major Bleeding in Patients With Atrial Fibrillation Looking Behind the Curtain
    Nelson, Adam J.
    Alexander, John H.
    CIRCULATION, 2019, 140 (22) : 1802 - 1804
  • [8] Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation
    Steinberg, Benjamin A.
    Ballew, Nicholas G.
    Greiner, Melissa A.
    Lippmann, Steven J.
    Curtis, Lesley H.
    O'Brien, Emily C.
    Patel, Manesh R.
    Piccini, Jonathan P.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (12) : 1384 - 1392
  • [9] Anticoagulation Use and Clinical Outcomes Following Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation
    Hernandez, Inmaculada
    Zhang, Yuting
    Brooks, Maria M.
    Chin, Paul K.
    Saba, Samir
    CIRCULATION, 2016, 134
  • [10] Anticoagulation Use and Clinical Outcomes Following Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation
    Hernandez, Inmaculada
    Zhang, Yuting
    Brooks, Maria M.
    Chin, Paul K.
    Saba, Samir
    CIRCULATION, 2016, 134